Hotel Palace Berlin,
Berlin, Germany
Commercializing EVs: The Technical Blueprint for Batch Consistency, Higher Yields, and Clinical Clearance
From Targeted Drug Delivery to Breakthrough Therapeutics. Bridge the Gap between Discovery and Commercial Reality to Expedite your EV Pipelines to Patients.
Early Bird Rates End Soon
Save on your pass when you book before Friday, 17 July 2026.
Visionary EV Leaders Taking Center Stage at Exosomes Europe
These trailblazers are going to leave a lasting impact on the Extracellular Vesicles landscape, delivering essential strategies to propel products from discovery to clinical trials and into commercial success.
The Technical Blueprints Shaping Extracellular Vesicle Commercialization
Explore the exact operational themes defining this year's program: built specifically to advance your extracellular vesicle pipeline from benchtop scale to clinical reality.
Resolve Biomanufacturing Bottlenecks & Scale Up Production
- Overcome Upstream Scalability Hurdles: Evaluate data-driven methodologies for bioreactor scale-up, automated cultures, and high-density cell-line hubs to meet delivery demands.
- Optimize Downstream Purification Dynamics: Implement next-generation chromatography to maximize yield, manage biological impurities, and ensure robust viral clearance without compromising structural stability.
- Enforce Batch Consistency & Quality Control: Mitigate fluid shear sensitivity and utilize chemically defined media to eliminate donor-dependent variability across the entire manufacturing lifecycle.
Decode EV Heterogeneity & Validate Functional Efficacy
- Characterize Complex EV Populations: Overcome bulk analysis limitations by deploying single-vesicle analysis and high-resolution molecular profiling to isolate specific sub-types and therapeutic biomarkers.
- Establish Mechanistic & Potency Validation: Accelerate functional cargo validation using integrated multi-omics approaches and predictive in vitro and in vivo bioactivity mechanisms.
- Evaluate Next-Gen Delivery Platforms: Cutting-edge clinical progression of native tissue-specific secretomes, thermoresponsive hydrogel formulations, and engineered non-mammalian alternative vectors.
De-Risk Regulatory CMC & Accelerate Clinical Translation
- Validate Release Criteria & Potency Assays: Build multi-parametric potency testing frameworks that align directly with current guidelines and global regulatory requirements for cell-free therapeutics.
- Global Harmonization: Address the standardization crisis through implementation of counting, tracking, and defining valid extracellular vesicle products guidleines.
- Secure Path to Market Approval: Cross the translational "valley of death" using real-world lessons from active Phase 1/2 clinical programs navigating the evolving FDA and EMA regulatory landscapes.
New Co-located Events
Your Exosomes Europe registration also unlocks full access to 2 industry-leading events that connect 500+ global experts driving viral and non-viral delivery innovation.
Triple the content. Triple the connections. Triple the impact.
All included with your Exosomes Europe Pass.
From Breakthrough Science to Industrial Reality: Scaling Affordable, Accessible Cell and Gene Therapies
Go beyond theory: Delivering real gains in manufacturing efficiency, commercial scalability, and cost of goods reduction for ATMPs
Master the strategies to propel lipid nanoparticles from development to market. Discover the latest breakthroughs in tissue-specific targeting, scalable manufacturing, advanced characterisation, and next-generation LNPs, driving safer, more effective non-viral delivery solutions and therapies.
Top EV Companies at Exosomes Europe 2026
What does Exosomes Europe have for YOU?
Innovative Decision Makers
This event is your opportunity to navigate the competitive landscape, de-risk your pipeline, understand emerging regulations and build the partnerships needed to commercialize the next generation of EV therapeutics.
Scientific Problem Solvers
Join your peers for deep dives into the critical technical hurdles of EV development. Get practical solutions for early stage development, complex downstream processing, and analytical characterisation.
Where Advanced Modality Innovation Meets Industry Application
This isn't just one conference; our co-located trio of events are catalyst for the collaborations that will define the future of medicine all under one roof.
We've built in dedicated synchronised networking sessions across Exosomes Europe, CGTI Europe, and LNPs Europe to help you find your next partner, secure collaboration, or in-license technology that can help to complete your pipeline.
Engage a qualified audience of exosome-focused scientists, biotech innovators, and therapeutic development leaders!
Whether you're looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.
To learn more about sponsorship opportunities and connect with an account manager, contact us directly at partners@informaconnectls.com